Search results
AMGEN TO PRESENT INNOVATIVE RHEUMATOLOGY RESEARCH AT EULAR 2024
Morningstar· 5 days agoData Highlight Positive Outcomes in Uncontrolled Gout With KRYSTEXXA® and Progress in Addressing Sjögren's Disease THOUSAND OAKS, Calif., June 12, 2024 /PRNewswire/ -- Amgen ...
Arthrosi Presents Positive Phase 2 Data for AR882 at the European Alliance of Associations for...
KPVI· 3 days agogout. "We are excited to share new data from our Phase 2 trial of AR882 highlighting its long-term durability of effect and strong safety profile, further building on the ...
Northwest Wealth Management LLC Makes New $242,000 Investment in Amgen Inc. (NASDAQ:AMGN)
ETF DAILY NEWS· 5 days agoThe institutional investor bought 840 shares of the medical research company’s stock, valued at approximately $242,000. Several other institutional investors have also made changes to their positions in the stock.
Novel URAT1 Inhibitors Advance for Gout
MedPage Today· 3 days agoImproved drugs to force uric acid excretion as a means of treating gout are inching closer to clinical availability in the U.S., with new data reported...
Raleigh Capital Management Inc. Decreases Stake in Amgen Inc. (NASDAQ:AMGN)
ETF DAILY NEWS· 1 day agoRaleigh Capital Management Inc. lessened its stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 34.2% in the fourth quarter, HoldingsChannel.com reports. The firm owned 6,138 shares ...
Scilex (NASDAQ:SCLX) Given Buy Rating at HC Wainwright
ETF DAILY NEWS· 5 days agoHC Wainwright reaffirmed their buy rating on shares of Scilex (NASDAQ:SCLX – Free Report) in a research note issued to investors on Tuesday morning, Benzinga reports. HC Wainwright currently ...
DASH vs. the Mediterranean Diet: Heart-Healthy, But Very Different
The Sacramento Bee· 4 days agoThe DASH diet and the Mediterranean diet have similar cardiovascular, immunity and weight loss benefits. Jordan Hill, RD, of Top Nutrition Coaching tells Woman’s World that although DASH is ...